A House Oversight subcommittee is calling for transcribed interviews from eight top FDA officials relating to the infant formula shortage.
"The more the Oversight Committee uncovers in our investigation into internal failures at the FDA which led our nation into an infant formula crisis, the more questions we have for the FDA," Subcommittee Chairwoman Lisa McClain said.A whistleblower filed an FDA complaint in October 2021 regarding hazardous bacteria at the Abbott Laboratories plant in Michigan that produced the majority of powered baby formula in the U.S.
Mayne said in her testimony that streamlining"the reporting and decision-making" process as well as"organizational changes could make a more efficient or effective program."
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
House Oversight panel seeks briefing from Secret Service on cocaine found in White HouseThe House Oversight Committee is in the process of requesting a briefing from the Secret Service on the cocaine that was found in the West Wing of the White House on Sunday night, a spokesperson for the committee confirmed.
Weiterlesen »
Studiocanal Germany Announces Quartet Of Promotions; CEO To Have Oversight Of Top Polish Distrib Kino ŚwiatStudiocanal Germany CEO Kalle Friz’s remit has expanded to include oversight of top Polish film distributor and Studiocanal subsidiary Kino Świat. He will carry out his new responsibilities as part…
Weiterlesen »
Denver's Citizen Oversight Board honors the 20th anniversary of Paul Childs' deathWednesday marks 20 years since Paul Childs was shot and killed by Denver police. The 15-year-old's death led to increased transparency and citizen oversight in the city.
Weiterlesen »
US FDA declines to approve Amneal's Parkinson's drug over safety concernsThe U.S. Food and Drug Administration (FDA) has declined to approve Amneal Pharmaceuticals' drug designed to help control symptoms in Parkinson's disease patients for a longer duration, citing inadequate safety data.
Weiterlesen »
FDA Gives The Okay For Abbott’s New Minimally Invasive PacemakerOn Wednesday, medtech giant Abbott announced that its new leadless pacemaker system, Aveir DR, has been approved by the FDA. This is the first time the FDA has given a thumbs up to a device of this type for two different chambers of the heart.
Weiterlesen »